Abstract
The aim of this study is to assess the procedure-to-delivery interval (PDI), the obstetric complications, and the early neonatal outcome in patients that did or did not receive glucocorticosteroids before third-trimester amniocentesis. A retrospective analysis of 445 third-trimester amniocentesis (TTA) procedures divided into two groups based on the administration (study group = 220 patients) or not (control group = 225 patients) of glucocorticosteroids before TTA. The PDI was calculated for all patients. Obstetric and neonatal outcomes were compared between the groups The rate of procedure-associated complications was similar between the groups. The mean PDI was 47.2±16.8 days. The overall incidence of preterm birth was 11.7%; 9% delivered between 34 and 37 weeks and 2.7% between 28 and 34 weeks. Only nine patients (2%) delivered within seven days following TTA. The incidence of respiratory distress syndrome in the study and control groups was 1.8% and 1.3%, p=0.71, respectively. There were no significant differences in other neonatal outcomes in term and preterm deliveries between the study and control groups. In the present study, the administration of glucocorticoids prior to TTA did not reduce the rates of neonatal complications, which was similar in both groups and not higher than the general population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.